US2014072996A1PendingUtilityA1
Methods and kits for detecting hemoglobin in test samples
Est. expiryJan 14, 2029(~2.5 yrs left)· nominal 20-yr term from priority
G01N 33/721G01N 21/76
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to methods of detecting hemoglobin in a test sample. These methods can be used to diagnose a subject suffering from a genetic disorder relating to hemoglobin metabolism, to determine the eligibility of a subject to be a blood donor, to determine the age of a stored blood sample or to identify a hemolyzed plasma sample. The present invention also relates to kits for use in the above described methods.
Claims
exact text as granted — not AI-modified1 .- 43 . (canceled)
44 : A kit for detecting hemoglobin in a test sample, the kit comprising:
a. at least one basic solution; b. at least one indicator solution, wherein the indicator solution comprises at least one acridinium compound; and c. instructions for detecting hemoglobin in a test sample.
45 : The kit of claim 44 , wherein the basic solution is a solution having a pH of at least about 10.
46 : The kit of claim 44 , wherein the acridinium compound is an acridinium-9-carboxamide having a structure according to formula I:
wherein R 1 and R 2 are each independently selected from the group consisting of: alkyl, alkenyl, alkynyl, aryl or aralkyl, sulfoalkyl, carboxyalkyl and oxoalkyl, and
wherein R 3 through R 15 are each independently selected from the group consisting of: hydrogen, alkyl, alkenyl, alkynyl, aryl or aralkyl, amino, amido, acyl, alkoxyl, hydroxyl, carboxyl, halogen, halide, nitro, cyano, sulfo, sulfoalkyl, carboxyalkyl and oxoalkyl; and optionally, if present, X ⊖ is an anion.
47 : The kit of claim 44 , wherein the acridinium compound is an acridinium-9-carboxylate aryl ester having a structure according to formula II:
wherein R 1 is an alkyl, alkenyl, alkynyl, aryl or aralkyl, sulfoalkyl, carboxyalkyl and oxoalkyl; and
wherein R 3 through R 15 are each independently selected from the group consisting of: hydrogen, alkyl, alkenyl, alkynyl, aryl or aralkyl, amino, amido, acyl, alkoxyl, hydroxyl, carboxyl, halogen, halide, nitro, cyano, sulfo, sulfoalkyl, carboxyalkyl and oxoalkyl; and optionally, if present, X ⊖ is an anion.
48 : The kit of claim 44 , wherein the indicator solution further comprises at least one surfactant.
49 - 50 . (canceled)
51 : A kit for diagnosing a subject suffering from a genetic disorder relating to hemoglobin metabolism, the kit comprising:
a. at least one basic solution; b. at least one indicator solution, wherein the indicator solution comprises at least one acridinium compound; and c. instructions for diagnosing a subject suffering from a genetic disorder relating to hemoglobin metabolism.
52 : The kit of claim 51 , wherein the basic solution is a solution having a pH of at least about 10.
53 : The kit of claim 51 , wherein the acridinium compound is an acridinium-9-carboxamide having a structure according to formula I:
wherein R 1 and R 2 are each independently selected from the group consisting of alkyl, alkenyl, alkynyl, aryl or aralkyl, sulfoalkyl, carboxyalkyl and oxoalkyl, and
wherein R 3 through R 15 are each independently selected from the group consisting of: hydrogen, alkyl, alkenyl, alkynyl, aryl or aralkyl, amino, amido, acyl, alkoxyl, hydroxyl, carboxyl, halogen, halide, nitro, cyano, sulfo, sulfoalkyl, carboxyalkyl and oxoalkyl; and optionally, if present, X ⊖ is an anion.
54 : The kit of claim 51 , wherein the acridinium compound is an acridinium-9-carboxylate aryl ester having a structure according to formula II:
wherein R 1 is an alkyl, alkenyl, alkynyl, aryl or aralkyl, sulfoalkyl, carboxyalkyl and oxoalkyl; and
wherein R 3 through R 15 are each independently selected from the group consisting of: hydrogen, alkyl, alkenyl, alkynyl, aryl or aralkyl, amino, amido, acyl, alkoxyl, hydroxyl, carboxyl, halogen, halide, nitro, cyano, sulfo, sulfoalkyl, carboxyalkyl and oxoalkyl; and optionally, if present, X ⊖ is an anion.
55 : The kit of claim 51 , wherein the indicator solution further comprises at least one surfactant.
56 : A kit for determining the eligibility of a subject to be a blood donor, the kit comprising:
a. at least one basic solution; b. at least one indicator solution, wherein the indicator solution comprises at least one acridinium compound; and c. instructions for determining the eligibility of a subject to be a blood donor.
57 : The kit of claim 56 , wherein the basic solution is a solution having a pH of at least about 10.
58 : The kit of claim 56 , wherein the acridinium compound is an acridinium-9-carboxamide having a structure according to formula I:
wherein R 1 and R 2 are each independently selected from the group consisting of: alkyl, alkenyl, alkynyl, aryl or aralkyl, sulfoalkyl, carboxyalkyl and oxoalkyl, and
wherein R 3 through R 15 are each independently selected from the group consisting of: hydrogen, alkyl, alkenyl, alkynyl, aryl or aralkyl, amino, amido, acyl, alkoxyl, hydroxyl, carboxyl, halogen, halide, nitro, cyano, sulfo, sulfoalkyl, carboxyalkyl and oxoalkyl; and optionally, if present, X ⊖ is an anion.
59 : The kit of claim 56 , wherein the acridinium compound is an acridinium-9-carboxylate aryl ester having a structure according to formula II:
wherein R 1 is an alkyl, alkenyl, alkynyl, aryl or aralkyl, sulfoalkyl, carboxyalkyl and oxoalkyl; and
wherein R 3 through R 15 are each independently selected from the group consisting of: hydrogen, alkyl, alkenyl, alkynyl, aryl or aralkyl, amino, amido, acyl, alkoxyl, hydroxyl, carboxyl, halogen, halide, nitro, cyano, sulfo, sulfoalkyl, carboxyalkyl and oxoalkyl; and optionally, if present, X ⊖ is an anion.
60 : The kit of claim 56 , wherein the indicator solution further comprises at least one surfactant.
61 : A kit for determining the age of a stored blood sample, the kit comprising:
a. at least one basic solution; b. at least one indicator solution, wherein the indicator solution comprises at least one acridinium compound; and c. instructions for determining the age of a blood sample.
62 : The kit of claim 61 , wherein the basic solution is a solution having a pH of at least about 10.
63 : The kit of claim 61 , wherein the acridinium compound is an acridinium-9-carboxamide having a structure according to formula I:
wherein R 1 and R 2 are each independently selected from the group consisting of: alkyl, alkenyl, alkynyl, aryl or aralkyl, sulfoalkyl, carboxyalkyl and oxoalkyl, and
wherein R 3 through R 15 are each independently selected from the group consisting of: hydrogen, alkyl, alkenyl, alkynyl, aryl or aralkyl, amino, amido, acyl, alkoxyl, hydroxyl, carboxyl, halogen, halide, nitro, cyano, sulfo, sulfoalkyl, carboxyalkyl and oxoalkyl; and optionally, if present, X ⊖ is an anion.
64 : The kit of claim 61 , wherein the acridinium compound is an acridinium-9-carboxylate aryl ester having a structure according to formula II:
wherein R 1 is an alkyl, alkenyl, alkynyl, aryl or aralkyl, sulfoalkyl, carboxyalkyl and oxoalkyl; and
wherein R 3 through R 15 are each independently selected from the group consisting of: hydrogen, alkyl, alkenyl, alkynyl, aryl or aralkyl, amino, amido, acyl, alkoxyl, hydroxyl, carboxyl, halogen, halide, nitro, cyano, sulfo, sulfoalkyl, carboxyalkyl and oxoalkyl; and optionally, if present, X ⊖ is an anion.
65 : The kit of claim 61 , wherein the indicator solution further comprises at least one surfactant.
66 : A kit for identifying a hemolyzed serum or plasma sample, the kit comprising:
a. at least one basic solution; b. at least one indicator solution, wherein the indicator solution comprises at least one acridinium compound; and c. instructions for identifying a hemolyzed serum or plasma sample.
67 : The kit of claim 66 , wherein the basic solution is a solution having a pH of at least about 10.
68 : The kit of claim 66 , wherein the acridinium compound is an acridinium-9-carboxamide having a structure according to formula I:
wherein R 1 and R 2 are each independently selected from the group consisting of: alkyl, alkenyl, alkynyl, aryl or aralkyl, sulfoalkyl, carboxyalkyl and oxoalkyl, and
wherein R 3 through R 15 are each independently selected from the group consisting of: hydrogen, alkyl, alkenyl, alkynyl, aryl or aralkyl, amino, amido, acyl, alkoxyl, hydroxyl, carboxyl, halogen, halide, nitro, cyano, sulfo, sulfoalkyl, carboxyalkyl and oxoalkyl; and optionally, if present, X ⊖ is an anion.
69 : The kit of claim 66 , wherein the acridinium compound is an acridinium-9-carboxylate aryl ester having a structure according to formula II:
wherein R 1 is an alkyl, alkenyl, alkynyl, aryl or aralkyl, sulfoalkyl, carboxyalkyl and oxoalkyl; and
wherein R 3 through R 15 are each independently selected from the group consisting of: hydrogen, alkyl, alkenyl, alkynyl, aryl or aralkyl, amino, amido, acyl, alkoxyl, hydroxyl, carboxyl, halogen, halide, nitro, cyano, sulfo, sulfoalkyl, carboxyalkyl and oxoalkyl; and optionally, if present, X ⊖ is an anion.
70 : The kit of claim 66 , wherein the indicator solution further comprises at least one surfactant.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.